Raymond James analyst Laura Prendergast downgraded Mural Oncology (MURA) to Outperform from Strong Buy with an $18 price target
Raymond James analyst Laura Prendergast downgraded Mural Oncology (MURA) to Outperform from Strong Buy with an $18 price target